Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • February 23 2017

    Biopharmaceuticals Ltd. announced the closing of their Registered Direct offering in the amount of $2,500,000.  EG&S acted as counsel to the Placement Agent.

  • February 21 2017

    Ellenoff Grossman & Schole LLP is proud to announce the addition of a new practice group – Immigration.  John Assadi joins EG&S as a Member and Mauricio Martinez as an Associate.

    Click here to view the announcement

  • February 15 2017

    Biostage, Inc. announced the closing of their Registered Direct offering in the amount of $8,000,000.  EG&S acted as counsel to the Placement Agent.

  • February 14 2017

    Moleculin Biotech, Inc. announced the closing of their Underwritten offering in the amount of $4,657,905.  EG&S acted as counsel to the Underwriter.

  • February 10 2017

    Real Goods Solar, Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000.  EG&S acted as counsel to the Placement Agent.

  • February 07 2017

    Ellenoff Grossman & Schole LLP is proud to announce the addition of a new attorney in our Corporate department.  His name is Jeffrey W. Rubin and he joins as a member of the Firm and specializes in corporate, M&A and securities law.

    Click here to read his announcement

  • February 06 2017

    Real Goods Solar, Inc. announced the closing of their Registered Direct offering in the amount of $11,484,869.  EG&S acted as counsel to the Placement Agent.

  • February 06 2017

    Hemispherx Biopharma, Inc. announced the closing of their Registered Direct offering in the amount of $1,000,001.  EG&S acted as counsel to the Placement Agent.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”